Publication | Closed Access

Discovery of 3,3-di(indolyl)indolin-2-one as a novel scaffold for α-glucosidase inhibitors: In silico studies and SAR predictions

Medicinal Chemistryα-Glucosidase InhibitorsBiochemistryNatural SciencesMedicineDiversity-oriented SynthesisSar PredictionsNovel ScaffoldDrug DevelopmentPharmacologyMolecular ModelingPharmaceutical ChemistryInhibitory ActivityDrug DiscoveryGlycosylation